Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD

OBJECTIVE: To evaluate the value of soluble urokinase-type plasminogen activator receptor (suPAR) in the diagnosis of acute exacerbation of COPD (AECOPD) and in monitoring treatment response, analyzing the relationship between suPAR and fibrinogen in AECOPD. AECOPD leads to increased airway inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: AboEl-Magd, Gehan Hassan, Mabrouk, Maaly Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104538/
https://www.ncbi.nlm.nih.gov/pubmed/29538541
http://dx.doi.org/10.1590/S1806-37562017000000151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104538/
https://www.ncbi.nlm.nih.gov/pubmed/29538541
http://dx.doi.org/10.1590/S1806-37562017000000151

Ejemplares similares